Osteomyelitis Clinical Trials

Find Osteomyelitis Clinical Trials Near You

BonE and Joint Infections - Simplifying Treatment in Children Trial

Who is this study for? Patients with Septic Arthritis, Bone and Joint Infection, Osteomyelitis
What treatments are being studied? Cefalexin
Status: Recruiting
Location: See all (11) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

This is a multi- centre trial of children with bone and joint infections (BJIs) at eleven major paediatric hospitals in Australia, New Zealand and Ireland. The primary objective is to establish if in children with acute, uncomplicated BJIs, entirely oral antibiotic treatment is not inferior to initial intravenous (IV) treatment for 1 to 7 days followed by an oral antibiotic course in achieving full recovery 3 months after presentation. Children will be randomly allocated to the 'entirely oral antibiotic' group or the 'standard treatment' group.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 18
Healthy Volunteers: f
View:

• Children aged 1 to 18 years with acute, uncomplicated, uncomplicated, haematogenous osteomyelitis or septic arthritis

• Symptoms are present for ≤10 days

• Osteomyelitis (OM): involvement of long bones of arm or leg AND either pain, point tenderness upon palpation of bone or joint, or difficulty weight bearing; OR Septic arthritis (SA): any of painful and/or swollen large joint; restriction of joint movement; tenderness or warmth. Those with both SA and OM at the same site as the current infection are also eligible.

• The participant has an elevated C-reactive protein (CRP) ≥20 mg/L or erythrocyte sedimentation rate (ESR) ≥10 mm/h

Locations
Other Locations
Australia
Women's and Children's Hospital
RECRUITING
Adelaide
Queensland Children's Hospital
RECRUITING
Brisbane
Royal Darwin Hospital
RECRUITING
Darwin
Nepean Hospital
RECRUITING
Kingswood
The Royal Children's Hospital
RECRUITING
Melbourne
John Hunter Children's Hospital
RECRUITING
New Lambton Heights
Perth Children's Hospital
RECRUITING
Perth
Sydney Children's Hospital Network
RECRUITING
Sydney
The Children's Hospital at Westmead
ACTIVE_NOT_RECRUITING
Sydney
Ireland
Children's Health Ireland
NOT_YET_RECRUITING
Dublin
New Zealand
Christchurch Hospital
RECRUITING
Christchurch
Contact Information
Primary
Alison Boast, MD
alison.boast@gmail.com
+61393455522
Backup
Amanda Gwee, PhD
amanda.gwee@rch.org.au
+61393455522
Time Frame
Start Date: 2021-06-01
Estimated Completion Date: 2028-02
Participants
Target number of participants: 214
Treatments
Active_comparator: Intervention
Children will receive high-dose oral cefalexin 37.5 mg/kg/dose (max 1.5 g) four-times daily (QID) for 1 to 7 days followed by oral cefalexin 45 mg/kg/dose (max 1.5 g) TDS for a total course of 3 weeks
Active_comparator: Standard Therapy
Children will receive IV cefazolin 50 mg/kg/dose (max 2 g) three-times daily (TDS) or IV flucloxacillin 50 mg/kg/dose (max 2 g) QID for 1 to 7 days followed by oral cefalexin 45 mg/kg/dose (max 1.5 g) TDS for a total course of 3 weeks
Sponsors
Leads: Murdoch Childrens Research Institute

This content was sourced from clinicaltrials.gov